Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-18

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved Accord Healthcare's supplemental application for mycophenolate mofetil, enabling the marketing of a generic version of this immunosuppressant u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)